← Eichor
Study identifier: NCT05726786 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

The Role of Preoperative Immunonutrition on Morbidity and Immune Response After Cystectomy (INCyst Trial)

Condition: Bladder Cancer · Interstitial Cystitis · Painful Bladder Syndrome  ·  Sponsor: Centre Hospitalier Universitaire Vaudois

PhasePhase 3
Planned participants232
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The goal of this clinical trial research study is to evaluate the impact of preoperative oral immunonutrition (IN) on post-operative complications in patients undergoing a cystectomy. As a secondary focus, this study will aim to develop a signature that would identify patients that would benefit the most from IN. This is a multicentric (Swiss: N=3), prospective, controlled, pragmatic, parallel-group comparative study with block randomization stratified by centers.

This description comes directly from the study's public registry record.

Talk to the study team

Ilaria Lucca, MD  ·  +41213142980  ·  ilaria.lucca@chuv.ch

Always discuss trial participation with your own doctor first.

Locations (4)

Centre Hospitalier Universitaire Vaudois, CHUVLausanne, Canton of Vaud, SwitzerlandRecruiting
University Hospital of BernBern, SwitzerlandRecruiting
University Hospital of GenevaGeneva, SwitzerlandRecruiting
Hospital of Riviera-ChablaisRennaz, SwitzerlandRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05726786